Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
5.50
+0.01 (0.27%)
Jun 29, 2026, 11:00 AM EDT - Market open
Annexon Market Cap
Annexon has a market cap or net worth of $900.31 million as of June 29, 2026. Its market cap has increased by 202.80% in one year.
Market Cap
900.31M
Enterprise Value
702.36M
1-Year Change
202.80%
Ranking
Category
Stock Price
$5.50
Market Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $900.31M, an increase of 40.78%. That is a compound annual growth rate of 5.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 900.31M | 20.32% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 948.94M |
| Pharming Group | 939.20M |
| LB Pharmaceuticals | 915.36M |
| Solid Biosciences | 914.60M |
| Janux Therapeutics | 911.11M |
| Theravance Biopharma | 908.88M |
| Evommune | 906.94M |
| Arbutus Biopharma | 904.72M |